Brain cell type–specific enhancer–promoter interactome maps and disease - risk association
University of California San Diego · University Medical Center Groningen · +7 more institutions
Abstract
Linking enhancers to disease Enhancers are genomic regions that regulate gene expression, sometimes in a cell-dependent manner. However, most of our knowledge of human brain cell–type enhancers derives from studies of bulk human brain tissue. Nott et al. examined chromatin and promoter activity in cell nuclei isolated from human brains. Genetic variants associated with brain traits and disease showed cell-specific patterns of enhancer enrichment. These data indicate that Alzheimer's disease is regulated by genetic variants within microglial cells, whereas psychiatric diseases tend to affect neurons. Science , this issue p. 1134
Citation impact
- FWCI
- 35.72
- Percentile
- 100%
- References
- 70
Authors
26- ANAlexi NottCorresponding
University of California San Diego
- IRInge R. HoltmanCorresponding
University Medical Center Groningen, University of Groningen, University of California San Diego
- NGNicole G. CoufalCorresponding
Salk Institute for Biological Studies, University of California San Diego
- JCJohannes C. M. Schlachetzki
University of California San Diego
- MYMiao Yu
Ludwig Cancer Research
Topics & keywords
- Enhancer
- Interactome
- Biology
- Microglia
- Phenotype
- Promoter
- Gene
- Cell type
- Good health and well-being
Funding
- UDU.S. Department of Veterans Affairs
- CRCancer Research Institute
- AAAlzheimer's AssociationAward: AARF-18-531498
- JFJPB Foundation
- CACure Alzheimer's Fund
- ULUniversité Laval
- LILudwig Institute for Cancer Research
- RGRijksuniversiteit Groningen
- CHCentre Hospitalier Universitaire de Québec
- UMUniversitair Medisch Centrum Groningen
- NINational Institutes of HealthAwards: NS109200-01, S10-OD023689, AG057706, 1P30AG062429, P30 014195, AG056511, KL2TR001444
- UOUniversity of California, San Diego
- VAVeterans Affairs San Diego Healthcare System
- NINational Institute on AgingAwards: AG062429-01, AG061060-01, AG056511-01, AG057706-01
- NCNational Cancer InstituteAward: P30-CA014195